LIFECORE BIOMEDICAL INC. - COMMON STOCK

Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

03 фев 2025 07:00:57 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Announces Special Stockholder Meeting

17 янв 2025 17:24:36 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

07 янв 2025 09:00:02 Источник Nasdaq GlobeNewswire

Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference

06 янв 2025 16:05:29 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update

02 янв 2025 16:05:31 Источник Nasdaq GlobeNewswire

Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

19 дек 2024 16:05:52 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

19 дек 2024 07:00:10 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

26 ноя 2024 16:05:31 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Hosts Virtual Investor Day

21 ноя 2024 16:17:32 Источник Nasdaq GlobeNewswire

Lifecore Biomedical to Present at Stephens Annual Investment Conference

12 ноя 2024 16:05:40 Источник Nasdaq GlobeNewswire

Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024

07 ноя 2024 07:00:55 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations

04 ноя 2024 07:00:04 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update

04 окт 2024 07:30:52 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock

04 окт 2024 07:20:10 Источник Nasdaq GlobeNewswire

Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024

03 окт 2024 16:05:19 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology

01 окт 2024 07:00:04 Источник Nasdaq GlobeNewswire

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

25 сен 2024 16:05:49 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational

19 сен 2024 07:00:57 Источник Nasdaq GlobeNewswire

Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference

12 сен 2024 16:05:06 Источник Nasdaq GlobeNewswire

Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements

12 сен 2024 07:00:50 Источник Nasdaq GlobeNewswire